NUVB Stock Analysis: Buy, Sell, or Hold?
NUVB - Nuvation Bio Inc.
$4.56
0.00 (0.00%)
▲
5d:
-10.76%
30d:
+7.29%
90d:
-18.72%
HOLD
MODERATE Confidence
Analysis Updated: Apr 28, 2026 12:00 AM ET
Earnings: May 04, 2026
4d
Smart Money Accumulation
NUVB is down 11.4% this week, but smart money is accumulating calls. Top strike: $5 2026-06-18 with 2,536 OI. Call ratio: 84% View Scanner →
Strength: 9.2/10
Get Alerted When NUVB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: NUVB trades at premium valuation expecting 153.6% growth. Hold existing positions but don't chase. Wait for better entry.
📊 HOLD: NUVB trades at premium valuation expecting 153.6% growth. Hold existing positions but don't chase. Wait for better entry.
In-depth Analysis How we analyze
Valuation Analysis: NUVB is currently trading at $4.56, which is considered fair relative to its 30-day fair value range of $4.31 to $4.91. From a valuation perspective, the stock is trading at a premium (Forward PE: 456.0) compared to its historical average (27.9). At these levels, the market is pricing in 153.6% annual earnings growth. This is a high bar to clear, indicating the stock may be priced for perfection.
Technical Outlook: Technically, NUVB is in a strong downtrend. The price is currently testing key support at $4.46. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: NUVB has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $12.33 (+170.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, NUVB is in a strong downtrend. The price is currently testing key support at $4.46. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: NUVB has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $12.33 (+170.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$4.31 -
$4.91
Company Quality Score
48/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
45.2%
Protect Your Profits
Holding NUVB? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 170.5% below Wall St target ($12.33)
- BEARISH: Market expects 153.6% growth - appears too optimistic based on history
- CAUTION: 5-day price weakness (-10.8%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$4.31 -
$4.91
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$4.46
Resistance Level
$5.29
Current Trend
Strong Downtrend
Technical data as of
Apr 28, 2026
Fundamental Context
Forward P/E (Next Year Est.)
456.00
Wall Street Target
$12.33
(+170.5%)
Revenue Growth (YoY)
633.1%
Valuation Premium vs History
+153.6% premium
PE vs Historical
456.0 vs 27.9
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+153.6%
(market-implied from PE analysis)
1-Year Target
$6.84
(+50%)
2-Year Target
$10.26
(+125%)
3-Year Target
$15.39
(+238%)
3-Yr Target (if PE normalizes)
(PE: 456→28)
PE COMPRESSION
$0.94
(-79%)
Significant PE compression expected
Share & Embed Analysis
Last updated: April 29, 2026 6:12 AM ET
Data refreshes hourly during market hours. Next update: 7:12 AM
Data refreshes hourly during market hours. Next update: 7:12 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NUVB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
9
Sells
Net
INSIDERS SELLING
Recent Transactions
Dongfang Liu
SELL
50000 shares
2026-04-17
Kerry Wentworth
SELL
36750 shares
2026-04-17
Kerry Wentworth
SELL
200000 shares
2026-04-06
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$89 | 57 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$99 | 57 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$93 | 55 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$30 | 59 HOLD |
Advanced NUVB Option Strategies
Professional options setups generated by AI based on today's NUVB price and gamma walls.